Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG

Clinical trial NCT03973918 · TERMINATED

Trial details

NCT number: NCT03973918
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

High Grade Glioma BRAF V600E BRAF V600K Anaplastic Astrocytoma Anaplastic Pleomorphic Xanthoastrocytoma Gliosarcoma Glioblastoma

Start date: 2019-07-29
Primary completion: 2022-04-30
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.